-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
4 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$383,681
Akebia Therapeutics, Inc. Insider Transactions
Akebia Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Hadas Nicole R.
SVP, Chief Legal Officer |
Sell | 12,016 @ $1.26 | $15,140 | 651,243 | 05/13/2024 | 05/14/2024 | |
|
Dahan Michel
SVP, COO |
Sell | 34,840 @ $1.26 | $43,898 | 672,092 | 05/13/2024 | 05/14/2024 | |
|
Dahan Michel
SVP, COO |
Sell | 8,661 @ $1.58 | $13,684 | 706,932 | 02/29/2024 | 03/01/2024 | |
|
Hadas Nicole R.
SVP, Chief Legal Officer |
Sell | 5,974 @ $1.58 | $9,439 | 663,259 | 02/29/2024 | 03/01/2024 | |
|
Butler John P.
CEO |
Sell | 46,570 @ $1.58 | $73,581 | 2,044,580 | 02/29/2024 | 03/01/2024 | |
|
Burke Steven Keith
SVP, Chief Medical Officer |
Sell | 7,169 @ $1.58 | $11,327 | 695,840 | 02/29/2024 | 03/01/2024 | |
|
Hadas Nicole R.
SVP, Chief Legal Officer |
Sell | 7,411 @ $1.52 | $11,265 | 669,233 | 02/27/2024 | 02/29/2024 | |
|
Dahan Michel
SVP, COO |
Sell | 10,744 @ $1.52 | $16,331 | 715,593 | 02/27/2024 | 02/29/2024 | |
|
Burke Steven Keith
SVP, Chief Medical Officer |
Sell | 8,367 @ $1.52 | $12,718 | 703,009 | 02/27/2024 | 02/29/2024 | |
|
Butler John P.
CEO |
Sell | 37,733 @ $1.52 | $57,354 | 2,091,150 | 02/27/2024 | 02/29/2024 | |
|
Butler John P.
CEO |
Sell | 46,489 @ $1.68 | $78,102 | 2,128,883 | 02/01/2024 | 02/02/2024 | |
|
Burke Steven Keith
SVP, Chief Medical Officer |
Sell | 24,311 @ $1.68 | $40,842 | 711,376 | 02/01/2024 | 02/02/2024 | |
|
Burke Steven Keith
SVP, Chief Medical Officer |
Sell | 27,000 @ $1.15 | $31,050 | 668,840 | 08/25/2023 | 05/09/2024 | |
|
Hadas Nicole R.
SVP, Chief Legal Officer |
Sell | 63,186 @ $1.22 | $77,270 | 524,344 | 05/25/2023 | 05/25/2023 | |
|
Dahan Michel
SVP, COO |
Sell | 95,478 @ $1.22 | $116,760 | 574,037 | 05/25/2023 | 05/25/2023 | |
|
Burke Steven Keith
SVP, Chief Medical Officer |
Sell | 63,567 @ $1.07 | $67,890 | 530,487 | 05/16/2023 | 05/18/2023 | |
|
Spellman David A
SVP, CFO and Treasurer |
Sell | 63,567 @ $1.07 | $67,890 | 446,483 | 05/16/2023 | 05/18/2023 | |
|
Butler John P.
CEO |
Sell | 38,259 @ $0.88 | $33,572 | 1,622,481 | 03/01/2023 | 03/03/2023 | |
|
Butler John P.
CEO |
Sell | 47,239 @ $0.88 | $41,452 | 1,575,242 | 03/01/2023 | 03/03/2023 | |
|
Butler John P.
CEO |
Sell | 6,370 @ $0.88 | $5,590 | 1,568,872 | 03/01/2023 | 03/03/2023 |
Akebia Therapeutics, Inc. Frequently Asked Questions
-
Who is on Akebia Therapeutics, Inc.'s Insider Roster?
The list of insiders at Akebia Therapeutics, Inc. includes Burke Steven Keith, Butler John P., Dahan Michel, Hadas Nicole R..
-
How much insider selling is happening at Akebia Therapeutics, Inc.?
Insiders have sold a total of 250,285 Akebia Therapeutics, Inc. shares in the last 12 months for a total of 383,681 sold.
-
Which Akebia Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Akebia Therapeutics, Inc. shares in the last 12 months: Burke Steven Keith ($64,887), Butler John P. ($209,036), Dahan Michel ($73,914), Hadas Nicole R. ($35,844),